U.S. Government: $2 BILLION on the way to Pfizer for COVID-19 antiviral treatment Paxlovid – Ivermectin and hydroxychloroquine cost $1 per treatment course – Pavloxid $530

Strange Sounds

December 19, 2022

The U.S. Government has agreed to pay Pfizer nearly $2 billion for an additional 3.7 million courses of its COVID-19 antiviral treatment, with the delivery of the remaining 20 million courses previously purchased planned for early 2023.

According to a report from CBS, Pfizer is expected to top $100 billion dollars in revenue, with more than half of it to come the COVID vaccines.

Read more…